Open Access Pub publishes peer-reviewed, free-to-read open-access articles. Showing
articles matching gastrointestinal — open any to read the full text,
or download the PDF or XML.
Feb 2018 DOI 10.14302/issn.2640-690X.jfm-17-1900
Alaa Ali M. ElzohryCorresponding author
Background PMPS nowadays is common due to advances in both; diagnosis and treatment of cancer breast. Choosing proper treatments can improve the patients’ quality of life. Cancer breast is common and quite important disease and female in our family must be aware of it. Improvement of the diagnosis a…
Jan 2018 DOI 10.14302/issn.2470-5020.jnrt-17-1926
Simon NagelCorresponding author
Since the first description in 2013, 39 cases of anti-DPPX-encephalitis have been described. Main features of this autoimmune encephalitis characterized by antibodies against the potassium-channel-associated regulatory protein DPPX are gastrointestinal symptoms, cognitive dysfunction and signs of CN…
Aug 2017 DOI 10.14302/issn.2574-4526.jddd-17-1688
Kian KeyashianCorresponding author
Patients with inflammatory bowel disease (IBD) frequently visit the emergency department (ED). The use of cputed tomography (CT) scans in this population has drastically increased in recent years and may confer an increased risk of malignancy. Records were obtained for IBD patients aged 18 or older…
Oct 2016 DOI 10.14302/issn.2574-4526.jddd-16-1153
Umair MasoodCorresponding author
A 69 year old female with a history of pancreatic mucinous cystadenoma (treated with Whipple procedure) and recently presumed liver cirrhosis presented to the hospital with melanotic stools. The source of the bleeding was initially thought to be secondary to upper gastrointestinal (GI) varices due t…
Jan 2015 DOI 10.14302/issn.2471-7061.jcrc-14-394
Petros C. PapagiorgisCorresponding author
This review synthesizes evidence on NSAIDs and colorectal cancer prevention. It balances chemopreventive efficacy against gastrointestinal and cardiovascular risks, and considers selective COX‑2 inhibitors, dosing, and candidate populations for risk‑benefit.